Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Goserelin acetate

Goserelin acetate

pharmaceutical raw materials
Goserelin acetate structure

Goserelin acetate 

structure
  • CAS No:

    145781-92-6

  • Formula:

    C59H84N18O14

  • Chemical Name:

    Goserelin acetate

  • Synonyms:

    PYR-HIS-TRP-SER-TYR-D-SER(TBU)-LEU-ARG-PRO-AZAGLY-NH2;[(T-BU)DSER6, (AZA)GLY10]-LH-RH;[(T-BU)DSER6, (AZA)GLY10]-LUTEINIZING HORMONE-RELEASING HORMONE;GLP-HIS-TRP-SER-TYR-D-SER(TBU)-LEU-ARG-PRO-AZA-GLY-NH2;(D-SER(TBU)6,AZAGLY10)-LHRH;(D-Ser(tBu)6,Azagly10)-LHRH acetate salt;Goserelin HCl;GOSERELIN HCL[PYR-HIS-TRP-SER-TYR-D-SER(T-BU)-LEU-ARG-PRO-AZAGLY-NH2]

  • Categories:

    Active Pharmaceutical Ingredients  >  Hormones and the Endocrine System

Description

White Solid

Goserelin acetate Basic Attributes

1269.41

1268.641439

1533716-785-6

2937190000

Characteristics

493.39000

-0.95

white powder

1.5±0.1 g/cm3

>190°C (dec.)

1695.5ºC at 760mmHg

1.692

H2O: 20 mg/mL, clear, colorless

−20°C

Safety Information

NONH for all modes of transport

3

22-24/25

OK6369800

P201-P280-P308 + P313

H360

Goserelin acetate Use and Manufacturing

Synthetic peptide agonist analog of LH-RH. Antineoplastic (hormonal).

Drug Function and Efficacy

This drug is a synthetic analog of luteinizing hormone-releasing hormone. Long-term use can inhibit the secretion of luteinizing hormone from the pituitary gland, thereby causing a decrease in male serum testosterone and female serum estradiol. This effect is reversible after discontinuation of the drug. About 21 days after the first dose of the drug, the testosterone concentration of male patients can be reduced to the level after castration. During the treatment process of taking the drug once every 28 days, the testosterone concentration has been maintained within the concentration range after castration. This testosterone inhibition can cause prostate tumors to regress and symptoms to improve in most patients. About 21 days after the first dose of the drug, the serum estradiol concentration of female patients is suppressed and maintained at the postmenopausal level during the subsequent 28-day treatment. This inhibition is associated with hormone-dependent breast cancer and endometriosis.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • AstraZeneca Pharmaceuticals LP

    United States United States
    Active
  • Bachem AG

    Switzerland Switzerland
    Active
  • Chinese Peptide Co., Ltd.

    China China
    Active

Recommended Suppliers of Goserelin acetate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.